• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受吸入性类固醇和长效β2受体激动剂治疗的稳定期哮喘患者体内的脂质过氧化物

Lipid peroxides in stable asthmatics receiving inhaled steroids and long-acting beta2 -agonists.

作者信息

Alzoghaibi Mohammed A, Bahammam Ahmed S

机构信息

Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

出版信息

Respirology. 2007 May;12(3):439-42. doi: 10.1111/j.1440-1843.2007.01034.x.

DOI:10.1111/j.1440-1843.2007.01034.x
PMID:17539852
Abstract

BACKGROUND AND OBJECTIVE

The effect of inhaled steroids on oxidative stress in asthmatics is unclear. The levels of lipid peroxides in the serum of asthmatic patients, whose symptoms were controlled with inhaled corticosteroids and long-acting beta(2)-agonists, were measured in this study.

METHODS

Twenty asthmatic patients and 17 matched, healthy controls were recruited. Oxidative stress levels were quantified by measuring thiobarbituric acid reactive substances.

RESULTS

After 3 months of treatment, the mean lipid peroxide concentrations were significantly higher in asthmatic patients than in the healthy controls (4.2 +/- 0.13 micromol/mL vs. 3.6 +/- 0.07 micromol/mL, respectively).

CONCLUSION

The level of lipid peroxides is higher in patients with asthma than in healthy controls, even when the asthma is well controlled after 3 months of treatment. A longer period of therapy may be required before lipid peroxidation normalizes.

摘要

背景与目的

吸入性类固醇对哮喘患者氧化应激的影响尚不清楚。本研究测定了使用吸入性糖皮质激素和长效β2受体激动剂控制症状的哮喘患者血清中脂质过氧化物的水平。

方法

招募了20名哮喘患者和17名匹配的健康对照者。通过测量硫代巴比妥酸反应性物质来量化氧化应激水平。

结果

治疗3个月后,哮喘患者的平均脂质过氧化物浓度显著高于健康对照者(分别为4.2±0.13微摩尔/毫升和3.6±0.07微摩尔/毫升)。

结论

即使哮喘在治疗3个月后得到良好控制,哮喘患者的脂质过氧化物水平仍高于健康对照者。可能需要更长时间的治疗才能使脂质过氧化恢复正常。

相似文献

1
Lipid peroxides in stable asthmatics receiving inhaled steroids and long-acting beta2 -agonists.接受吸入性类固醇和长效β2受体激动剂治疗的稳定期哮喘患者体内的脂质过氧化物
Respirology. 2007 May;12(3):439-42. doi: 10.1111/j.1440-1843.2007.01034.x.
2
[symbol: see text] Seretide and [symbol: see text] Symbicort in asthma management.[符号:见正文] 舒利迭和 [符号:见正文] 信必可都保在哮喘管理中的应用。
Drug Ther Bull. 2002 Aug;40(8):62-4.
3
Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.皮质类固醇与肾上腺素能受体激动剂:慢性气道疾病联合治疗的优势
Eur J Pharmacol. 2006 Mar 8;533(1-3):28-35. doi: 10.1016/j.ejphar.2005.12.049. Epub 2006 Feb 7.
4
Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.最佳哮喘治疗的双重成分:联合使用长效β受体激动剂与吸入性糖皮质激素的科学及临床依据
J Am Osteopath Assoc. 2001 Sep;101(9):526-33.
5
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.布地奈德/福莫特罗用于控制不佳哮喘的维持治疗和缓解与高剂量沙美特罗/氟替卡松的对比
Respir Med. 2007 Dec;101(12):2437-46. doi: 10.1016/j.rmed.2007.07.014. Epub 2007 Oct 1.
6
Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients.吸入性类固醇/长效β2受体激动剂联合制剂可使成年哮喘患者的肺功能在24小时内得到改善。
Respir Res. 2006 Aug 18;7(1):110. doi: 10.1186/1465-9921-7-110.
7
The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.CONCEPT试验:一项为期1年的多中心随机双盲双模拟试验,比较沙美特罗/丙酸氟替卡松稳定给药方案与福莫特罗/布地奈德可调整维持给药方案在持续性哮喘成人患者中的疗效。
Clin Ther. 2005 Apr;27(4):393-406. doi: 10.1016/j.clinthera.2005.03.006.
8
Combination therapy in asthma--fixed or variable dosing in different patients?哮喘的联合治疗——不同患者采用固定剂量还是可变剂量?
Curr Med Res Opin. 2004 Nov;20(11):1711-27. doi: 10.1185/030079904X3104.
9
Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.含有吸入性皮质类固醇和长效β2受体激动剂的联合吸入器:改善哮喘患者的临床疗效和给药选择。
J Asthma. 2005 Nov;42(9):715-24. doi: 10.1080/02770900500305748.
10
Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.福莫特罗常规治疗稳定期哮喘患者后β2肾上腺素能受体调节及支气管扩张剂敏感性
J Allergy Clin Immunol. 1998 Mar;101(3):337-41. doi: 10.1016/S0091-6749(98)70245-3.

引用本文的文献

1
Fermented and Aged Ginseng Sprouts () and Their Main Component, Compound K, Alleviate Asthma Parameters in a Mouse Model of Allergic Asthma through Suppression of Inflammation, Apoptosis, ER Stress, and Ferroptosis.发酵和陈化人参芽及其主要成分化合物K通过抑制炎症、细胞凋亡、内质网应激和铁死亡减轻过敏性哮喘小鼠模型中的哮喘参数
Antioxidants (Basel). 2022 Oct 18;11(10):2052. doi: 10.3390/antiox11102052.
2
Oxidative stress in patients with asthma and its relation to uncontrolled asthma.哮喘患者的氧化应激及其与未控制哮喘的关系。
J Clin Lab Anal. 2022 May;36(5):e24345. doi: 10.1002/jcla.24345. Epub 2022 Mar 22.
3
Oxidative stress in asthma.
哮喘中的氧化应激。
World Allergy Organ J. 2011 Oct;4(10):151-8. doi: 10.1097/WOX.0b013e318232389e. Epub 2011 Oct 10.
4
Glucocorticoid and estrogen receptors are reduced in mitochondria of lung epithelial cells in asthma.糖皮质激素和雌激素受体在哮喘患者的肺上皮细胞线粒体中减少。
PLoS One. 2012;7(6):e39183. doi: 10.1371/journal.pone.0039183. Epub 2012 Jun 27.
5
The effect of air pollution on asthma and allergy.空气污染对哮喘和过敏的影响。
Curr Allergy Asthma Rep. 2008 Apr;8(2):139-46. doi: 10.1007/s11882-008-0024-8.